Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
36,118,773
-
Shares change
-
+9,804,106
-
Total reported value, excl. options
-
$1,125,171,985
-
Value change
-
+$319,523,410
-
Put/Call ratio
-
3.2%
-
Number of buys
-
61
-
Number of sells
-
32
-
Price
-
$31.16
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2015
As of 30 Jun 2015 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,118,773 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Broadfin Capital, LLC, Partner Fund Management, L.P., FMR LLC, Cormorant Asset Management, LLC, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and VHCP Management, LLC.
This table shows 112 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.